Recce Pharmaceuticals Ltd (ASX:RCE)
Australia · Delayed Price · Currency is AUD 0.4200
+0.0050 (1.20%)
Oct 24, 2025, 3:14 PM AEST
Recce Pharmaceuticals Market Cap
Recce Pharmaceuticals has a market cap or net worth of 121.46 million as of October 24, 2025. Its market cap has decreased by -4.76% in one year.
Market Cap
121.46M
Enterprise Value
121.54M
Revenue
7.51M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.42
Market Cap Chart
Since January 15, 2016, Recce Pharmaceuticals's market cap has increased from 20.55M to 121.46M, an increase of 491.11%. That is a compound annual growth rate of 19.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 121.46M | 8.00% |
| Dec 31, 2024 | 112.46M | 3.19% |
| Dec 29, 2023 | 108.98M | -7.28% |
| Dec 30, 2022 | 117.53M | -34.34% |
| Dec 31, 2021 | 179.00M | -2.33% |
| Dec 31, 2020 | 183.27M | 279.76% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Jan 15, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 102.70B |
| Pro Medicus | 29.45B |
| Cochlear | 18.98B |
| Sonic Healthcare | 10.75B |
| Ramsay Health Care | 7.34B |
| Telix Pharmaceuticals | 5.59B |
| Ansell | 4.84B |
| Mesoblast | 3.30B |